Free Trial

Inotiv (NOTV) Competitors

Inotiv logo
$3.21 +0.42 (+15.05%)
(As of 11/20/2024 ET)

NOTV vs. LUNA, PIRS, PGEN, OCGN, IBEX, ABSI, QBTS, PMTS, ACCD, and SHAP

Should you be buying Inotiv stock or one of its competitors? The main competitors of Inotiv include Luna Innovations (LUNA), Pieris Pharmaceuticals (PIRS), Precigen (PGEN), Ocugen (OCGN), IBEX (IBEX), Absci (ABSI), D-Wave Quantum (QBTS), CPI Card Group (PMTS), Accolade (ACCD), and Spree Acquisition Corp. 1 (SHAP).

Inotiv vs.

Inotiv (NASDAQ:NOTV) and Luna Innovations (NASDAQ:LUNA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, community ranking, media sentiment and valuation.

In the previous week, Luna Innovations had 2 more articles in the media than Inotiv. MarketBeat recorded 4 mentions for Luna Innovations and 2 mentions for Inotiv. Luna Innovations' average media sentiment score of 0.17 beat Inotiv's score of 0.00 indicating that Luna Innovations is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inotiv
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Luna Innovations
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

18.2% of Inotiv shares are held by institutional investors. Comparatively, 87.5% of Luna Innovations shares are held by institutional investors. 5.8% of Inotiv shares are held by company insiders. Comparatively, 7.6% of Luna Innovations shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Luna Innovations has lower revenue, but higher earnings than Inotiv. Luna Innovations is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inotiv$501.06M0.17-$105.14M-$3.84-0.84
Luna Innovations$109.50M0.51$9.28M-$0.08-20.38

Inotiv has a beta of 3.36, meaning that its share price is 236% more volatile than the S&P 500. Comparatively, Luna Innovations has a beta of 1.63, meaning that its share price is 63% more volatile than the S&P 500.

Luna Innovations received 180 more outperform votes than Inotiv when rated by MarketBeat users. Likewise, 58.70% of users gave Luna Innovations an outperform vote while only 48.72% of users gave Inotiv an outperform vote.

CompanyUnderperformOutperform
InotivOutperform Votes
19
48.72%
Underperform Votes
20
51.28%
Luna InnovationsOutperform Votes
199
58.70%
Underperform Votes
140
41.30%

Inotiv presently has a consensus price target of $5.92, indicating a potential upside of 84.32%. Luna Innovations has a consensus price target of $8.00, indicating a potential upside of 390.80%. Given Luna Innovations' stronger consensus rating and higher probable upside, analysts plainly believe Luna Innovations is more favorable than Inotiv.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inotiv
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Luna Innovations
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Luna Innovations has a net margin of 0.00% compared to Inotiv's net margin of -19.80%. Luna Innovations' return on equity of 0.00% beat Inotiv's return on equity.

Company Net Margins Return on Equity Return on Assets
Inotiv-19.80% -15.55% -4.32%
Luna Innovations N/A N/A N/A

Summary

Luna Innovations beats Inotiv on 14 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NOTV vs. The Competition

MetricInotivCommercial physical research IndustryMedical SectorNASDAQ Exchange
Market Cap$83.47M$4.28B$5.06B$8.89B
Dividend YieldN/A1.65%4.97%4.06%
P/E Ratio-0.8444.6089.0213.30
Price / Sales0.1759.971,207.2881.01
Price / Cash6.2025.5039.1736.03
Price / Book0.313.086.085.74
Net Income-$105.14M$139.66M$119.07M$225.93M
7 Day Performance17.58%-2.11%-1.84%-1.32%
1 Month Performance88.82%14.92%-3.65%0.60%
1 Year Performance38.96%35.25%31.62%26.23%

Inotiv Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NOTV
Inotiv
1.5907 of 5 stars
$3.21
+15.1%
$5.92
+84.3%
+41.4%$83.47M$501.06M-0.842,055News Coverage
Gap Up
High Trading Volume
LUNA
Luna Innovations
2.2056 of 5 stars
$1.63
-0.6%
$8.00
+390.8%
-71.9%$55.69M$109.50M0.00337
PIRS
Pieris Pharmaceuticals
2.0996 of 5 stars
$16.01
+2.7%
N/A-10.4%$20.58M$42.81M-1.32140Analyst Upgrade
News Coverage
PGEN
Precigen
3.7679 of 5 stars
$0.84
+5.0%
$7.00
+736.6%
-30.9%$233.01M$6.22M0.00202Analyst Revision
OCGN
Ocugen
1.3147 of 5 stars
$0.92
+4.6%
$5.67
+516.9%
+124.1%$254.50M$6.04M0.0065Analyst Forecast
IBEX
IBEX
1.7143 of 5 stars
$20.02
+0.8%
$21.25
+6.1%
+10.4%$333.12M$508.57M10.5930,000Gap Up
High Trading Volume
ABSI
Absci
1.4611 of 5 stars
$2.68
-1.5%
$8.67
+223.4%
+83.6%$307.81M$4.21M-2.88210
QBTS
D-Wave Quantum
2.2867 of 5 stars
$1.68
+12.8%
$2.63
+56.7%
+92.5%$300.13M$8.76M0.003Gap Up
PMTS
CPI Card Group
4.093 of 5 stars
$27.75
+4.6%
$36.50
+31.5%
+77.7%$295.95M$444.55M21.181,448
ACCD
Accolade
4.8358 of 5 stars
$3.56
+2.0%
$9.04
+154.0%
-55.7%$286.71M$441.03M-3.392,400Short Interest ↓
SHAP
Spree Acquisition Corp. 1
N/A$10.91
flat
N/AN/A$283.07MN/A0.00N/A

Related Companies and Tools


This page (NASDAQ:NOTV) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners